Table 1.
Asymptomatic n = 98 n (%) |
Non‐severe n = 110 n (%) |
Severe n = 42 n (%) |
RR: non‐severe vs asymptomatic | RR: severe vs asymptomatic | |
---|---|---|---|---|---|
Ethnicity | |||||
White | 70 (71.4) | 77 (70.0) | 26 (61.9) | 1+ | 1+ |
Other | 28 (28.6) | 33 (30.0) | 16 (38.1) | 1.2 (0.9–1.6) | 1.6 (0.4–2.6) |
Age | |||||
≤29 | 43 (43.9) | 28 (25.5) | 13 (31.0) | 1+ | 1+ |
30–33 | 21 (21.4) | 36 (32.7) | 10 (23.8) | 1.6 (1.1–2.3) | 1.4 (0.7–2.8) |
≥34 | 34 (34.7) | 46 (41.8) | 19 (45.2) | 1.5 (1.0–2.1) | 1.5 (0.8–2.8) |
Parity | |||||
1 | 37 (38.5) | 53 (48.2) | 16 (38.1) | 1+ | 1+ |
2 | 59 (61.5) | 57 (51.8) | 26 (61.9) | 0.8 (0.7–1.1) | 1.0 (0.6–1.7) |
BMI | |||||
≤24.99 | 64 (66.0) | 61 (57.6) | 23 (56.1) | 1+ | 1+ |
25–29.99 | 23 (23.7) | 31 (29.3) | 8 (19.5) | 1.2 (0.9–1.5) | 1.0 (0.5–1.9) |
≥30 | 10 (10.3) | 14 (13.2) | 10 (24.4) | 1.2 (0.8–1.7) | 1.8 (1.1–3.2) |
Comorbidity a | |||||
No | 88 (89.8) | 94 (85.5) | 34 (81.0) | 1+ | 1+ |
Yes | 10 (10.2) | 16 (14.6) | 8 (19.1) | 1.1 (0.8–1.5) | 1.5 (0.8–2.7) |
Abbreviations: BMI, body mass index; RR, relative risks.
Obesity is excluded among the following co‐morbidities and analysed in the BMI classes: Diabetes (13.4%), endocrinopathies (13.4%), respiratory diseases (11.9%), hypertension (5.9%), and autoimmune disorders (4.4%).